Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69effa084f6a06657c21de19 — DOI: https://doi.org/10.1161/01.cir.98.9.839

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Statins do more than just lower cholesterol· 1996 · 702 citations
2. Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies.· 1994 · 83 citations
3. Non-Lipid-Related Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors· 2008 · 90 citations
4. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis· 1994 · 88 citations
5. C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction· 1998 · 1,024 citations